[1] |
Jo VY, Fletcher CDM.
WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition[J]. PathologyPathology, 2014, 46(2): 95-104.
doi: 10.1097/PAT.0000000000000050 |
[2] |
朱艳, 刘兰, 张瑜, 等.
原发性骨淋巴瘤的18F-FDG PET/CT显像特点分析[J]. 中国医学影像学杂志中国医学影像学杂志, 2017, 25(2): 116-120.
doi: 10.3969/j.issn.1005-5185.2017.02.010 Zhu Y, Liu L, Zhang Y, et al. Features of 18F-FDG PET/CT imaging of primary lymphoma of bone[J]. Chin J Med ImagingChin J Med Imaging, 2017, 25(2): 116-120. doi: 10.3969/j.issn.1005-5185.2017.02.010 |
[3] |
吴枕戈, 郑汉朋, 邱乾德.
原发性骨淋巴瘤影像表现[J]. 中国临床医学影像杂志中国临床医学影像杂志, 2016, 27(6): 431-434.
Wu ZG, Zheng HP, Qiu QD. Imaging finding of primary bone lymphoma[J]. J China Clin Med ImagingJ China Clin Med Imaging, 2016, 27(6): 431-434. |
[4] |
Liu YY.
The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma[J]. Nucl Med CommunNucl Med Commun, 2017, 38(4): 319-324.
doi: 10.1097/MNM.0000000000000652 |
[5] |
郭锐, 李囡, 方志伟, 等.
18F-FDG PET/CT在骨破坏鉴别诊断中的应用[J]. 中华肿瘤防治杂志中华肿瘤防治杂志, 2018, 25(8): 581-585.
doi: 10.16073/j.cnki.cjcpt.2018.08.011 Guo R, Li N, Fang ZW, et al. Value of 18F-FDG-PET/CT in patients with synchronous multiple primary carcinomas[J]. Chin J Cancer Prev TreatChin J Cancer Prev Treat, 2018, 25(8): 581-585. doi: 10.16073/j.cnki.cjcpt.2018.08.011 |
[6] |
吴新武, 陈顺有.
儿童原发性骨淋巴瘤2例报告并文献复习[J]. 中外医学研究中外医学研究, 2020, 18(23): 186-188.
doi: 10.14033/j.cnki.cfmr.2020.23.074 Wu XW, Chen SY. A report of 2 cases with primary bone lymphoma of children and literature review[J]. Chin Foreign Med ResChin Foreign Med Res, 2020, 18(23): 186-188. doi: 10.14033/j.cnki.cfmr.2020.23.074 |
[7] |
Thornton E, Krajewski KM, O'regan KN, et al.
Imaging features of primary and secondary malignant tumours of the sacrum[J]. Br J RadiolBr J Radiol, 2012, 85(1011): 279-286.
doi: 10.1259/bjr/25247602 |
[8] |
杨东, 安立龙, 孙满顿, 等.
原发性骨淋巴瘤的影像诊断及误诊分析[J]. 医学影像学杂志医学影像学杂志, 2017, 27(8): 1550-1553.
Yang D, An LL, Sun MD, et al. The analysis on imageology dignosis and misdiagnosis for primary lymphoma of bone[J]. J Med ImagingJ Med Imaging, 2017, 27(8): 1550-1553. |
[9] |
刘子君, 文剑明.
骨原发性非何杰金氏恶性淋巴瘤的病理[J]. 中华肿瘤杂志中华肿瘤杂志, 1986, (5): 352-354.
Liu ZJ, Wen JM. Pathology of primary non-Hodgkin's malignant lymphoma of bone[J]. Chin J OncolChin J Oncol, 1986, (5): 352-354. |
[10] |
孙悦, 许宏, 郭振清, 等.
探索18F-FDG PET/CT SUVmax、SUVsum及病理Ki67表达等在非霍奇金淋巴瘤中的临床应用价值[J]. 临床血液学杂志临床血液学杂志, 2021, 34(1): 18-23.
doi: 10.13201/j.issn.1004-2806.2021.01.005 Sun Y, Xu H, Guo ZQ, et al. Explore the clinical value of 18F-FDG PET/CT SUVmax, SUVsum and pathological Ki67 expression in non-Hodgkin's lymphoma[J]. J Clin HematolJ Clin Hematol, 2021, 34(1): 18-23. doi: 10.13201/j.issn.1004-2806.2021.01.005 |
[11] |
Adams HJA, de Klerk JMH, Fijnheer R, et al.
Prognostic value of anemia and C-reactive protein levels in diffuse large B-cell lymphoma[J]. Clin Lymphoma Myeloma LeukClin Lymphoma Myeloma Leuk, 2015, 15(11): 671-679.
doi: 10.1016/j.clml.2015.07.639 |